These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16211396)

  • 1. Treatment of hyperlipidemia associated with Niemann-Pick disease type B by fenofibrate.
    Choi JH; Shin YL; Kim GH; Hong SJ; Yoo HW
    Eur J Pediatr; 2006 Feb; 165(2):138-9. PubMed ID: 16211396
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute cholestatic hepatitis probably due to fenofibrate].
    Maroy B
    Therapie; 2010; 65(2):147-8. PubMed ID: 20578346
    [No Abstract]   [Full Text] [Related]  

  • 3. Micronized fenofibrate in the management of dyslipidemia.
    Steiner G
    Diabetes Care; 1998 Nov; 21(11):2039-40. PubMed ID: 9802773
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of fenofibrate and gemfibrozil on plasma homocysteine.
    Bostom AG
    Lancet; 2001 Nov; 358(9295):1811-2. PubMed ID: 11734262
    [No Abstract]   [Full Text] [Related]  

  • 5. Fenofibrate in hyperlipidaemia secondary to HIV protease inhibitors. Fenofibrate and HIV protease inhibitor.
    de Luis DA; Bachiller P; Aller R
    Nutrition; 2001 May; 17(5):414-5. PubMed ID: 11377136
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of fenofibrate on brachial artery flow-mediated dilatation in type 2 diabetes mellitus.
    Playford DA; Watts GF; Best JD; Burke V
    Am J Cardiol; 2002 Dec; 90(11):1254-7. PubMed ID: 12450611
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of fenofibrate or gemfibrozil on serum lipid profiles in Chinese patients with type IIb hyperlipidemia: a single-blind, randomized, and cross-over study.
    Jen SL; Chen JW; Lee WL; Wang SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Apr; 59(4):217-24. PubMed ID: 9216117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenofibrate and diabetic retinopathy.
    Fagan XJ; Chong EW
    Clin Exp Ophthalmol; 2015; 43(4):297-9. PubMed ID: 26099043
    [No Abstract]   [Full Text] [Related]  

  • 9. Ezetimibe and fenofibrate combination therapy for mixed hyperlipidemia.
    Moon YS; Chun P; Chung S
    Drugs Today (Barc); 2007 Jan; 43(1):35-45. PubMed ID: 17315051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Other antihyperuricemic agents].
    Ogino K; Igawa O; Hisatome I
    Nihon Rinsho; 2008 Apr; 66(4):754-7. PubMed ID: 18409527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pleiotrophic effect of anti-hyperlipemic agents].
    Morishita R
    Nihon Naika Gakkai Zasshi; 2001 Oct; 90(10):2017-22. PubMed ID: 11769493
    [No Abstract]   [Full Text] [Related]  

  • 12. Micronized fenofibrate: a new fibric acid hypolipidemic agent.
    Guay DR
    Ann Pharmacother; 1999 Oct; 33(10):1083-103. PubMed ID: 10534222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and efficacy of fenofibrate/pravastatin combination therapy in high risk patients with mixed hyperlipidemia not controlled by pravastatin monotherapy.
    Farnier M; Ducobu J; Bryniarski L
    Curr Med Res Opin; 2011 Nov; 27(11):2165-73. PubMed ID: 21973199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-lowering drugs and homocysteine.
    de Lorgeril M; Salen P; Paillard F; Lacan P; Richard G
    Lancet; 1999 Jan; 353(9148):209-10. PubMed ID: 9923885
    [No Abstract]   [Full Text] [Related]  

  • 15. Fenofibric acid for hyperlipidemia.
    Saurav A; Kaushik M; Mohiuddin SM
    Expert Opin Pharmacother; 2012 Apr; 13(5):717-22. PubMed ID: 22404421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reversibility of severe hyperlipemia secondary to indinavir with micronized phenofibrate].
    de Luis DA; Aller R; Rachiller P; Ignacio Tortosa J
    Med Clin (Barc); 1999 Nov; 113(18):716-7. PubMed ID: 10650577
    [No Abstract]   [Full Text] [Related]  

  • 17. Fenofibrate increases creatininemia by increasing metabolic production of creatinine.
    Hottelart C; El Esper N; Rose F; Achard JM; Fournier A
    Nephron; 2002; 92(3):536-41. PubMed ID: 12372935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein A-V genetic variation and plasma lipoprotein response to fibrates.
    Hegele RA; Pollex RL
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1224-7. PubMed ID: 17522394
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrates and homocysteine.
    Young IS; Woodside JV
    Nutrition; 2001; 17(11-12):973-4. PubMed ID: 11744353
    [No Abstract]   [Full Text] [Related]  

  • 20. Fenofibrate-Induced elevation in serum creatinine.
    Ritter JL; Nabulsi S
    Pharmacotherapy; 2001 Sep; 21(9):1145-9. PubMed ID: 11560205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.